In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival

Overview of attention for article published in Molecular Cancer, October 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 14,841 followers.

For transplant-ineligible #myeloma patients, clonotypic tumor burden before treatment reflects event free survival (http://t.co/yReH8WpJ).

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.